(Q34053101)

30 July 2017

title

HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate (English)

1 reference

30 July 2017

1 reference

1 reference

Mi-Hye Lee

1

1 reference

30 July 2017

Samar M Hammad

2

1 reference

30 July 2017

Andrea J Semler

3

1 reference

30 July 2017

Louis M Luttrell

4

1 reference

30 July 2017

Maria F Lopes-Virella

5

1 reference

30 July 2017

Richard L Klein

6

1 reference

30 July 2017

language of work or name

1 reference

3 June 2010

1 reference

Journal of Lipid Research

30 July 2017

published in

1 reference

30 July 2017

volume

51

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

2619-2628

1 reference

Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Role of adipose tissue in haemostasis, coagulation and fibrinolysis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Export and functions of sphingosine-1-phosphate.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Sphingosine 1-phosphate receptor signaling

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Autocrine and paracrine roles of sphingosine-1-phosphate

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Physiological and pathological actions of sphingosine 1-phosphate.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

HDL cholesterol and protective factors in atherosclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Regulation of reverse cholesterol transport and clinical implications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Sphingosine-1-phosphate: an enigmatic signalling lipid

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Insulin and sterol-regulatory element-binding protein-1c (SREBP-1C) regulation of gene expression in 3T3-L1 adipocytes. Identification of CCAAT/enhancer-binding protein beta as an SREBP-1C target

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Sphingosine 1-phosphate receptors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Fat cell function and fibrinolysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Plasminogen-activator inhibitor type 1 and coronary artery disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level.

28 July 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Pleiotropic actions of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918445

Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles

28 October 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M003988

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

21 January 2018

1 reference

12 December 2020

Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2

1 reference

12 December 2020

Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes

1 reference

12 December 2020

Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

1 reference

12 December 2020

Relationship between blood fibrinoytic activity and body fatness

1 reference

12 December 2020

Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry

1 reference

12 December 2020

Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells

1 reference

12 December 2020

Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1

1 reference

12 December 2020

High-fat/high-cholesterol diet promotes a S1P receptor-mediated antiapoptotic activity for VLDL

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1194/JLR.M003988

1 reference

30 July 2017

1 reference

30 July 2017

1 reference